|
Originally published In Press as doi:10.1074/jbc.M110947200 on April 30, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24265-24273, July 5, 2002
Control of Calcium Homeostasis by Angiotensin II in Adrenal
Glomerulosa Cells through Activation of p38 MAPK*
Irina
Startchik ,
Dominique
Morabito ,
Ursula
Lang , and
Michel F.
Rossier §¶
From the Division of Endocrinology and Diabetology,
Department of Internal Medicine, and the § Laboratory of
Clinical Chemistry, Department of Pathology, University Hospital,
CH-1211 Geneva 14, Switzerland
Received for publication, November 15, 2001, and in revised form, March 26, 2002
 |
ABSTRACT |
Angiotensin II-induced activation of aldosterone
secretion in adrenal glomerulosa cells is mediated by an increase of
intracellular calcium. We describe here a new
Ca2+-regulatory pathway involving the inhibition by
angiotensin II of calcium extrusion through the
Na+/Ca2+ exchanger. Caffeine reduced both the
angiotensin II-induced calcium signal and aldosterone production in
bovine glomerulosa cells. These effects were independent of cAMP or
calcium release from intracellular stores. The calcium response to
angiotensin II was more sensitive to caffeine than the response to
potassium, suggesting that the drug interacts with a pathway
specifically elicited by the hormone. In calcium-free medium, calcium
returned more rapidly to basal levels after angiotensin II stimulation
in the presence of caffeine. Thapsigargin had no effect on these
kinetics, but diltiazem, which inhibits the
Na+/Ca2+ exchanger, markedly reduced the rate
of calcium decrease and abolished caffeine action. The involvement of
this exchanger was supported by the effect of cell depolarization and
of a reduction of extracellular sodium on the rate of calcium
extrusion. We also determined the mechanism of angiotensin II action on
the exchanger. Phorbol esters reduced the rate of calcium extrusion,
which was increased by baicalein, an inhibitor of lipoxygenases, and by SB 203580, an inhibitor of the p38 MAPK. Finally, we showed that angiotensin II acutely activates, in a caffeine-sensitive manner, p38
MAPK in glomerulosa cells. In conclusion, in bovine glomerulosa cells, the Na+/Ca2+ exchanger plays a crucial
role in extruding calcium, and, by reducing its activity, angiotensin
II influences the amplitude of the calcium signal. The hormone exerts
its action on the exchanger through a caffeine-sensitive pathway
involving the p38 MAPK and lipoxygenase products.
 |
INTRODUCTION |
It has been firmly established that cellular calcium signaling in
bovine adrenal glomerulosa cells plays a crucial role upon stimulation of aldosterone production by angiotensin II
(AngII)1 or
extracellular potassium, and the mechanisms of calcium mobilization by
these agonists have been reviewed in detail (1-3). Whereas K+ principally activates voltage-operated calcium channels
of both L and T type through direct membrane depolarization (4), the Ca2+ response to AngII appears biphasic; a first acute
elevation of [Ca2+]c due to Ca2+
release from intracellular stores is followed by a sustained response
reflecting the activation of Ca2+ influx through channels
of the plasma membrane. This second phase is maintained by the activity
of both voltage-gated and store-operated Ca2+ channels.
Beside these basic pathways of Ca2+ mobilization,
additional mechanisms have been proposed to participate or to modulate
the Ca2+ signal elicited by AngII in bovine adrenal
glomerulosa cells. For example, the participation of the
Na+/Ca2+ exchanger (NCX) in Ca2+
transport (in one direction or the other) during cell exposure to AngII
has been suggested (2, 5). Moreover, the protein kinase C (PKC) wing of
AngII signaling probably also regulates, directly or indirectly, the
Ca2+ messenger system. Although it was proposed earlier
that activation of this enzyme is essential for the steroidogenic
response to Ca2+-mobilizing hormones (6), the same authors
reported an inhibition of the phospholipase C by the phorbol ester
phorbol 12-myristate 13-acetate (PMA) (7), and the activation of PKC
has been also shown to be responsible for acute inhibition of T type
Ca2+ channels (8).
In addition to the phospholipase C-mediated formation of
diacylglycerol, AngII also stimulates the production of arachidonic acid by activation of a phospholipase A2 (9) or from
diacylglycerol through a diacylglycerol lipase (10). However, there is
scant information concerning the exact relationship between PKC,
phospholipase A2, and diacylglycerol lipase in steroidogenic
cells. Nevertheless, arachidonic acid serves as a substrate for various
enzymes that will further convert it into leukotrienes, prostaglandins,
or hydroxyeicosatetraenoic acids (HETEs). The latter, and more
specifically the 12-lipoxygenase products, have been proposed for many
years to play an important role in aldosterone synthesis (11, 12). Interestingly, 12-HETE appears to be directly involved in the generation of the AngII-elicited Ca2+ signal, because this
response is prevented by lipoxygenase blockers such as baicalein and
restored by the addition of 12-HETE (13).
Mitogen-activated protein kinases (MAPKs) are a family of ubiquitous
and highly conserved serine-threonine protein kinases activated by
diverse stimuli ranging from cytokines, growth factors, neurotransmitters, hormones, cellular stress, and cell adherence (14).
Mammalian MAPKs have been classified in three groups, which differ in
their activation pathway and include the MAPK extracellular
signal-regulated kinase (also referred as p42/44 MAPK), the MAPK c-Jun
N-terminal kinase, and the MAPK p38. Angiotensin II, through its AT1
receptor, has been shown to activate p42/44 MAPK in bovine adrenal
fasciculata cells (15) as well as in bovine and rat glomerulosa cells
(16, 17), an effect probably linked to the action of this hormone on
cell proliferation (18). This activation, easily detected by measuring
the phosphorylated forms of the enzymes, is maximal after a few minutes
and appears mediated by various effectors including PKC and the
Ras/Raf-1 kinase pathway (19).
In contrast, the activation of the p38 MAPK by AngII in glomerulosa
cells is poorly documented, despite the fact that the hormone has been
shown to induce an increase in p38 activity in vascular smooth muscle
cells, particularly under high glucose conditions (20). Recently, it
has been reported that AngII leads to a dose-dependent
increase in p38 MAPK activity in H295R adrenocortical cells, an effect
mimicked by the addition of 12-HETE (21). In contrast, no action of the
hormone was observed on the activity of the stress-activated MAPK c-Jun
N-terminal kinase. The authors also indicate that AngII-induced
aldosterone stimulation was significantly attenuated by a specific p38
MAPK inhibitor but not by an inhibitor of the MEK/ERK pathway.
In the present study, we have analyzed the mechanisms by which
caffeine, a drug known to interfere with multiple targets involved in
cell signaling, exerts its action on the intracellular Ca2+
response elicited by AngII in bovine adrenal glomerulosa cells. After
excluding multiple cellular mechanisms, we found that Ca2+
extrusion out of the cytosol through the plasma membrane NCX is
negatively modulated by p38 MAPK and demonstrate that caffeine, a
potent inhibitor of this regulatory pathway, maintains a high rate of
calcium extrusion during hormonal stimulation.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Antimycin, bovine serum albumin,
Bu2cAMP, caffeine, chelerythrine chloride, creatine
phosphokinase, DNase, EGTA, forskolin, Hepes, horseradish
peroxidase-coupled anti-goat antibody, 3-isobutyl-1-methylxanthine, ionomycin, insulin/transferrin/selenium, LaCl3, ATP,
nicardipine, oligomycin, oxalate, phosphocreatine disodium salt,
phenylmethylsulfonyl fluoride, polyvinyl alcohol, pyruvate, rotenone,
succinate, thapsigargin, and Triton X-100 were obtained from Sigma.
D-glucose, EDTA, TEMED, and Tween 20 were purchased from
Merck, and SB 203580 and PD 98059 were from Calbiochem.
Ins(1,4,5)P3, 45Ca2+, and ECL
hyperfilm were obtained from Amersham Biosciences; fura-2/AM, fluo-3/AM, fluo-4/AM, fura2 acid, and K4BAPTA were from
Molecular Probes, Inc. (Eugene, OR); and Dulbecco's modified Eagle's
medium, metyrapone, fetal calf serum, horse serum, and nystatin were
from Invitrogen. Acrylamide, baicalein, and diltiazem were
obtained from Fluka Chemie AG (Buchs, Switzerland). AngII was purchased from Bachem (Bubendorf, Switzerland), anti-rabbit antibody coupled to
horseradish peroxidase enzyme was from CovalAb (Lyon, France); dispase
was from Roche Molecular Biochemicals; garamycin was from ESSEX Chemie
AG (Lucerne, Switzerland), glycine was from Axon Lab AG
(Baden-Dättwil, Switzerland), M199 was from Biochrom KG (Berlin,
Germany), metyrapone was from Aldrich, okadaic acid and PMA were from
LC Laboratories (Woburn, MA), penicillin was from Hoechst-Pharma AG
(Zürich, Switzerland), Percoll was from Amersham Biosciences, SDS
was from Chemie Brunschwig, streptomycin was from Grünenthal
(Stolberg, Germany), and Ultima Gold was from Packard Instrument Co.
(Meriden, CT).
Isolation and Culture of Bovine Glomerulosa Cells--
Bovine
adrenals were obtained from a local slaughterhouse, and glomerulosa
cells were prepared by enzymatic dispersion with dispase and purified
on a Percoll density gradient, as previously described in detail
(22).
For primary culture, cells were transferred to antibiotic-containing
Dulbecco's modified Eagle's medium, supplemented with insulin/transferrin/selenium (2 µg/ml insulin, 2 µg/ml transferrin, 2 ng/ml sodium selenite), 5 µM metyrapone, 2 mM glutamine, 6 units/ml nystatin, 2% (v/v) fetal calf
serum, and 10% (v/v) horse serum. The cells were plated on 6- or
24-well culture plates (2 or 0.7 × 106 cells/well)
and incubated overnight at 37 °C in 5% CO2. The next day, the medium was removed and replaced with serum-free Dulbecco's modified Eagle's medium.
Measurement of Calcium Concentration in Intact
Cells--
Cytosolic calcium concentrations
[Ca2+]c were determined with fluorescent probes
in freshly prepared cell populations as previously described (8).
For this purpose, freshly purified cells were washed three times with
50 ml of Krebs-Ringer buffer and maintained in this medium for at least
60 min at 37 °C. Cells were then centrifuged, diluted at a
concentration of 4 × 106 cells/ml, and incubated in
the presence of 2 µM fura-2/AM, 5 µM
fluo-3/AM, or 5 µM fluo-4/AM. The dye excess was then
washed away, and cells were maintained in the same medium. Immediately before use, aliquots of 2 × 106 cells were washed and
diluted in appropriate experimental medium.
The fluorescent signals (excitation at 340/380 nm and emission at 505 nm for fura-2, and excitation at 488 nm and emission at 540 nm for
fluo-3 and fluo-4) were recorded with a Jasco (Hachioji City, Japan)
CAF-110 fluorescence spectrometer. Calcium concentrations were
calculated as described elsewhere (23), using a Kd value of 224 nM for fura-2 and 325 nM for
fluo-3 and fluo-4.
Mathematical Analysis of Calcium Extrusion Rate--
Calcium
traces, recorded in Ca2+-free, EGTA (0.2 mM)-supplemented Krebs-Ringer medium, were digitized at a
frequency of 2 Hz and analyzed with a mathematical analysis program
(Origin version 4.1). The decreasing phase of the response to AngII
(Fig. 4) during the extrusion of calcium out of the cytosol was fitted
over a 2-min period to a decreasing exponential function of the first order: y(t) = y0 + A × exp[ (t t0)/t1/2], where
y(t) is the value of
[Ca2+]c as a function of time,
y0 is the final calcium level reached after
calcium extrusion from the cytosol, A is the amplitude of
the calcium release peak, t0 is the beginning of
the analysis interval (15 s after the calcium release peak), and
t1/2 is the time constant corresponding to the
half-life of calcium in the cytosol or more precisely the time taken by
the cells to reach a cytosolic calcium level corresponding to 36.9%
(1/e) of the initial concentration (at
t0). This latter parameter
(t1/2), determined after optimizing the fitting
curve, reflects the rate of calcium extrusion out of the cytosol and
was used to assess the action of various agents on calcium homeostasis.
Measurement of Calcium Release from the Organelles in
Permeabilized Cells--
For measuring Ins(1,4,5)P3- and
caffeine-induced calcium release from the organelles, glomerulosa cells
were first permeabilized, as previously described (24). Freshly
prepared cells were washed twice with M199 (2.66 g/liter modified
Hanks' medium, 15 mM NaHCO3, 3.5 mM KCl, 120 mM NaCl) and once with Krebs-Ringer
buffer. They were then incubated for 10 min in a Ca2+-free
Krebs-Ringer solution supplemented with 50 µM EGTA. After incubation, cells were washed twice in 50 ml of permeabilization buffer
(250 mM sucrose and 5 mM Hepes, pH 7.2). Cells
were then permeabilized in a minimal volume by repeated (8-12 times)
brief (100 µs) exposure to an intense electric field (1400 V/cm).
Under these conditions, ~90% of treated cells were stained with
trypan blue.
Before use, cells were washed and placed in an intracellular-like
buffer (5 mM NaCl, 115 mM KCl, 5 mM
NaHCO3, 1 mM KH2PO4, 0.05% (w/v) bovine serum albumin, and 20 mM Hepes, pH 7.2)
at 37 °C under constant agitation. Cell autofluorescence was
determined before adding free acid fura-2 (2 µM), Mg-ATP
(2 mM), phosphocreatine disodium salt (10 mM),
creatine phosphokinase (8 IU/ml), succinate (5 mM),
pyruvate (5 mM), rotenone (0.1 µM), and
oligomycin (1 µM) to initiate calcium incorporation into
the organelles. After reaching a low steady state calcium level, tested
agents were added directly into the ambient medium, and calcium
fluctuations were followed by recording fura-2 fluorescent signal, as
in intact cells. Calcium responses were calibrated by the addition of
known amounts of CaCl2 into the medium after inhibition of
calcium incorporation into the organelles with thapsigargin and ionomycin.
In experiments assessing 45Ca2+ incorporation
into the organelles, permeabilized cells were maintained at 4 °C
until adding the reaction buffer (100 mM KCl, 25 mM Hepes, 2 mM KH2PO4,
5 mM MgCl2, pH 7.4) containing 1 µCi/ml
45Ca2+, an ATP-regenerating system (3 mM MgATP, 10 mM phosphocreatine disodium salt,
8 IU/ml creatine phosphokinase), mitochondrial inhibitors (10 µM antimycin, 1 µg/ml oligomycin), 5 mM
oxalate, and drugs to be tested. The free Ca2+
concentration in the medium was fixed at ~1 µM with 4.5 mM CaCl2 and 5 mM BAPTA. Cells
(samples of 2-3 × 106) were immediately incubated
for 15 min at 37 °C, and calcium uptake was stopped by the addition
of 2 mM LaCl3 at 0 °C. Cells were then
poured on Whatmann GF/B filters, and calcium excess was washed with
2 × 4 ml of washing buffer (250 mM sucrose, 40 mM NaCl, at 4 °C). Radioactivity retained on the filters
was measured in a Packard 1900 TR counter after adding 10 ml of UltimaGold.
Aldosterone Production--
Aldosterone production was
determined in the medium of cells in primary culture. Two days after
replacing culture medium by serum-free Dulbecco's modified Eagle's
medium, plated cells were washed three times with Krebs-Ringer buffer
and incubated for 30 min at 37 °C in the same solution containing
different experimental drugs. After this first incubation, the medium
was discarded and replaced by a fresh one of the same composition, and
the cells were incubated for an additional 60-min period. At the
end, the media were collected and centrifuged for 5 min at 1500 × g. The supernatants were frozen until aldosterone
determination by direct radioimmunoassay, using a commercially
available kit (Diagnostic Systems Laboratories, Webster, TX).
Aldosterone production was expressed per mg of cell protein, itself
measured in each dish with the Coomassie Blue method (Bio-Rad).
Determination of p38 MAPK Activation in Cultured Glomerulosa
Cells--
The relative activity of the p38 MAPK was assessed by
measuring the enzyme-phosphorylated form by immunoblotting. For this purpose, primary cultured cells were used 24-60 h after having been
deprived of serum. After a 30-min preincubation at 37 °C with
various agents tested, cells were stimulated for the indicated periods
of time with AngII (100 nM). At the end of the stimulation period, cells were washed with cold phosphate buffer (137 mM NaCl, 1.47 mM
KH2PO4, 10 mM
Na2HPO4, 2.7 mM KCl, pH 7.2) and
scraped into 75 µl of lysis buffer (50 mM Tris, 150 mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 2 mM EDTA, 2 mM EGTA, 40 mM
-glycerol phosphate, 50 mM NaF, 10 mM sodium
pyrophosphate, 200 µM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 100 nM
okadaic acid, pH 7.4). The homogenates were centrifuged at 4 °C for
10 min at 50,000 × g, and supernatants collected for
protein assay and Western blot analysis. Cell lysates (20 µg) were
analyzed by SDS-PAGE (electrophoretic migration was performed during 40 min at 150 V and protein transfer during 1.5 h at 110 V). After transfer, the nitrocellulose membranes were incubated in a blocking buffer (50 mM Tris/HCl, 200 mM NaCl, 0.2%
Tween 20, and 5% nonfat dried milk) for 1 h at room temperature.
For total p38 MAPK detection, dried milk was replaced by polyvinyl
alcohol (1%) in the blocking buffer. Membranes were then incubated for
2 h in the same buffer containing 1% nonfat dried milk or
polyvinyl alcohol with polyclonal antibodies raised against
phosphorylated p38 MAPK (New England BioLabs, Beverly, MA) or total p38
MAPK (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). The membranes
were washed with the same buffer without milk or polyvinyl alcohol and
then incubated for 1 h with horseradish peroxidase-labeled goat
anti-rabbit (CovalAb, Oullins, France) or rabbit anti-goat (Sigma)
antibodies. After washing six times for 10 min, the immunoreactive
bands were visualized by ECL detection reagent (Amersham Biosciences)
and quantified by densitometry (Molecular Dynamics, Inc., Sunnyvale, CA).
Statistics--
Statistical significance of differences was
assessed by the Student's t test. Probability values of
p < 0.05 were considered as being statistically significant.
 |
RESULTS |
Effect of Caffeine on Calcium Signaling and Steroidogenesis in
Adrenal Glomerulosa Cells--
Caffeine was initially used for
investigating the presence and the role of various types of
intracellular Ca2+ stores in the response of bovine adrenal
glomerulosa cells to a challenge with AngII. Surprisingly, we observed
that, when added during the sustained phase of the Ca2+
response to AngII, caffeine (2 mM) markedly reduced
[Ca2+]c in freshly isolated glomerulosa cells
(Fig. 1A). After inhibition by
caffeine, nicardipine, a dihydropyridine antagonist, had only a slight
effect on calcium levels. Interestingly, the same concentration of
caffeine only marginally affected the calcium response to KCl (Fig.
1B) that remained sensitive to nicardipine. Moreover, no
additional effect of caffeine was observed when maximal capacitative
Ca2+ influx was concomitantly triggered by 200 nM thapsigargin (not shown). The analysis of the
concentration dependence of the caffeine-induced inhibition of the
Ca2+ signal (Fig. 1C) revealed that caffeine is
much more efficient at reducing the response to AngII (IC50 = 1.3 mM) than the response to potassium (IC50 > 10 mM), suggesting that the drug interacts with a
mechanism specifically generated by AngII.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Caffeine-induced inhibition of the calcium
and steroidogenic responses to angiotensin II in bovine adrenal
glomerulosa cells. Fura-2-loaded freshly isolated bovine
glomerulosa cells were challenged, in the presence of extracellular
calcium (1.2 mM), with 100 nM AngII
(A) or 9 mM KCl (B) before being
exposed to caffeine (caff) and nicardipine (nic).
Calcium levels during the plateau phase (before the addition of
caffeine) and after the inhibition of the signal with nicardipine were
determined as described under "Experimental Procedures." The
concentration-dependent inhibition of the sustained calcium
signal by caffeine (C) was calculated as a percentage of the
maximal inhibition induced by nicardipine from traces similar to those
presented in A and B. Data are mean values ± S.E. from 13 experiments. D, bovine glomerulosa cells in
primary culture were incubated for 1 h in the presence or absence
of 100 nM AngII and with increasing concentrations of
caffeine. Aldosterone was measured in the medium by direct
radioimmunoassay and normalized to the amount of cell protein. Data
(mean ± S.E. from nine independent experiments) are expressed as
a percentage of the aldosterone induced by AngII in control cells (no
caffeine), and that amounted to 106 ± 10 ng aldosterone/mg of
prot/h. *, p < 0.0001.
|
|
The consequence of calcium inhibition by caffeine on the steroidogenic
response to AngII was investigated in primary cultured bovine
glomerulosa cells (Fig. 1D). Whereas basal aldosterone production appeared unaffected by caffeine, AngII-stimulated
aldosterone was significantly reduced by 56 ± 5% in the presence
of 10 mM caffeine. Aldosterone synthesis was not sensitive
to lower concentrations of the drug, despite the marked decrease of the
calcium signal observed previously, suggesting that AngII-induced
steroidogenesis is also controlled by additional pathways, compensating
for the partial decrease of calcium, or that the sensitivity of
glomerulosa cells to caffeine is different in freshly prepared cells,
used for calcium measurements, and in primary culture.
Lack of Caffeine Effect on Calcium Release from Intracellular
Stores--
To determine the site and mechanism of caffeine action on
AngII-induced calcium signaling, we first measured whether caffeine affects intracellular calcium pools. Preliminary experiments performed with intact cells showed that caffeine (10 mM) had no
effect on [Ca2+]c in unstimulated cells and did
not significantly reduce the amplitude of the transient
[Ca2+]c response to AngII (data not shown).
Additional experiments directly assessed the action of caffeine on
Ins(1,4,5)P3-sensitive and -insensitive stores in
permeabilized glomerulosa cells (Fig. 2).
Whereas the addition of micromolar concentrations of
Ins(1,4,5)P3 induced an immediate and transient release of
calcium into the ambient medium, low millimolar concentrations of
caffeine were inefficient and did not prevent a subsequent response to
Ins(1,4,5)P3 (Fig. 2A). The integrity of the
pools was finally tested by sequential addition of 400 nM
thapsigargin, an inhibitor of intracellular Ca2+-ATPases
(SERCA), and 2 µM ionomycin, a Ca2+
ionophore. The lack of caffeine-sensitive intracellular
Ca2+ pools in bovine glomerulosa cells was confirmed by
adding increasing concentrations of ryanodine, a drug acting on the
same type of Ca2+ stores as caffeine and which could not
induce calcium release in permeabilized (Fig. 2B) as well as
in intact glomerulosa cells (data not shown). Moreover, the presence of
10 mM caffeine in the medium did not affect the functional
response to Ins(1,4,5)P3 (Fig. 2C). Indeed,
EC50 values determined in the absence and in the presence
of 10 mM caffeine (0.59 and 0.45 µM,
respectively) were not significantly different, a finding in agreement
with the previous observation that the peak response to AngII was
unaffected by caffeine in intact cells.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Intracellular calcium stores are insensitive
to caffeine in bovine glomerulosa cells. Freshly prepared
glomerulosa cells were permeabilized by using high voltage electric
field discharges, as described under "Experimental Procedures," and
ambient calcium concentration fluctuations were recorded at 37 °C
with free acid fura-2. After the addition of ATP and accumulation of
ambient calcium into the organelles (not shown), cells were exposed to
various concentrations of Ins(1,4,5)P3
(IP3), caffeine (caff), or ryanodine. At
the end of each trace, Ca2+ was totally released from the
organelle by the successive addition of 400 nM thapsigargin
(thapsi) and 2 µM ionomycin (iono),
and calcium responses were normalized by the addition of known amounts
of CaCl2 in the medium (not shown).
|
|
Caffeine Action Is Not Mediated by cAMP--
To exclude the
possibility that caffeine could modulate calcium levels through an
inhibition of the phosphodiesterases and a subsequent elevation of cAMP
concentration, we measured the effect of various agents affecting cAMP
on Ca2+ homeostasis. As shown in Fig.
3, forskolin (25 µM), a
pharmacological activator of adenylyl cyclases, was unable to reduce
the AngII-induced [Ca2+]c plateau and did not
prevent caffeine action. The efficacy of forskolin was indirectly
assessed in parallel experiments by measuring aldosterone secretion
(Fig. 3, inset). At the same concentration (25 µM), forskolin appeared as potent as AngII (100 nM) to stimulate steroidogenesis, most probably through
activation of the cAMP pathway, which, like calcium, is a well
recognized modulator of aldosterone biosynthesis. The same results have
been obtained with either 3-isobutyl-1-methylxanthine (100 µM), an inhibitor of the cAMP phosphodiesterase, or the
cell-permeant analog Bu2cAMP (1 mM). Thus, it
appears that caffeine action on [Ca2+]c is not
mediated by a change in cAMP levels.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Caffeine-induced inhibition of the calcium
signal does not involve the cAMP pathway. Intact fura-2-loaded
cells were stimulated with 100 nM AngII, as in Fig.
1A, but 25 µM forskolin was added before the
inhibition by caffeine (caff). This trace is representative
of five independent experiments giving similar results.
Inset, aldosterone production by cells exposed to 25 µM forskolin was determined as in Fig. 1D and
compared with aldosterone secreted by control or AngII-stimulated
cells. nic, nicardipine.
|
|
Caffeine Accelerates Calcium Extrusion Out of the Cytosol--
A
reduction of [Ca2+]c, as illustrated in Fig.
1A, can result either from a decrease of calcium influx into
the cytosol or from an activation of calcium extrusion. This second
possibility was tested by exposing fura-2-loaded cells to AngII in the
absence of extracellular calcium. We observed, after a transient
response exclusively due to calcium release from intracellular stores, a dramatic acceleration of calcium lowering back to basal levels in the
presence of 10 mM caffeine as compared with control cells (Fig. 4). A systematic analysis of the
rate of calcium extrusion was performed by fitting the decreasing phase
of the calcium response to a single exponential function and by
comparing the time constants (t1/2). Caffeine
significantly reduced calcium half-life in the cytosol, decreasing
t1/2 from 0.67 ± 0.04 min in control cells to
0.35 ± 0.03 min (Fig. 4, inset).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Caffeine increases calcium extrusion out of
the cytosol after AngII-induced release. Intact fura-2-loaded
cells were stimulated with 100 nM AngII in a
Ca2+-free medium (containing 0.2 mM EGTA),
supplemented or not with 10 mM caffeine (caff).
The rate of Ca2+ extrusion out of the cytosol was
determined by fitting the decreasing phase of the calcium response,
occurring during the 2-min period following the calcium release peak,
to a single exponential function of the form:
y(t) = y0 + Ae( (t t0)/t1/2), with the time
constant t1/2 representing the "half-life" of
the stimulated calcium in the cytosol. Inset, mean
t1/2 values ± S.E. were determined from the
analysis of 50 independent traces obtained with control and
caffeine-treated cells. Similar experiments were then performed after
inhibiting SERCA pumps with 2 µM thapsigargin
(n = 10). *, p < 0.05; ***,
p < 0.005.
|
|
The role of SERCA pumps in calcium extrusion and its possible
activation by caffeine was then investigated by repeating the same
experiments in the presence of 2 µM thapsigargin, added
immediately before AngII. The presence of the latter drug did not
significantly affect the kinetics of calcium extrusion and did not
prevent caffeine action, suggesting that the activity of SERCA pumps is
not limiting in this process.
This result was confirmed by the observation that the
ATP-dependent 45Ca2+ uptake into
the stores of permeabilized cells (152 ± 11 nmol of
Ca2+/mg of protein/15 min) was not increased by 10 mM caffeine (128 ± 8 nmol/mg of protein/15 min,
n = 4). Similar results were obtained in the presence
of 100 nM AngII (123 ± 13 and 105 ± 19 nmol/mg of protein/15 min in control cells and in caffeine-treated cells, respectively).
Involvement of the
Na+/Ca2+ Exchanger in
Ca2+ Extrusion--
In order to test the role of the
NCX in Ca2+ extrusion from the cytosol, we
pretreated the cells with 50 µM diltiazem, a known inhibitor of this protein, before inducing calcium release with AngII
in the absence of extracellular Ca2+. Under these
conditions, we observed a marked decrease of the rate of calcium
extrusion, the t1/2 value increasing from 0.7 to 2.7 min (Fig. 5, Ctrl). This
result suggests that the activity of the NCX controls the rate of
Ca2+ extrusion. It is noteworthy that an inhibition by
diltiazem of the voltage-operated Ca2+ channels is unlikely
to be responsible for this effect on Ca2+ extrusion,
because Ca2+ is absent from the medium and because the
addition of nifedipine, another blocker of these channels, did not
change the kinetics of calcium extrusion (data not shown). Diltiazem
treatment did not affect the size of the peak due to the
Ca2+ release phase. Moreover, after inhibition of the NCX
with diltiazem, caffeine was not any more efficient, indicating that it
probably interferes with this pathway of Ca2+ extrusion.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Diltiazem decreases calcium extrusion and
prevents caffeine action. Intact cells were exposed to 50 µM diltiazem, in a Ca2+-free medium, before
being stimulated with 100 nM AngII, in the presence or in
the absence of 10 mM caffeine (caff), and the
rate of calcium extrusion was assessed as described in the legend to
Fig. 4. Inset, mean t1/2 values ± S.E. are compared with those obtained with untreated cells. ***,
p < 0.005; n.s., not significantly
different.
|
|
The role of the NCX in bringing Ca2+ back to basal levels
after release from the stores was confirmed 1) by decreasing the
concentration of extracellular Na+ or 2) by depolarizing
the cells with KCl. Indeed, when [Na+]o was
reduced from 140 down to 15 mM, Ca2+ extrusion
after release by AngII was markedly impaired (Fig. 6, inset). Actually, at low
[Na+]o, cells were unable to bring
[Ca2+]c back to basal levels, even in the absence
of extracellular Ca2+, a fact probably reflecting the
establishment of a new steady state and impairing analysis of kinetics.
We therefore calculated the ratio between the
[Ca2+]c plateau measured after 3.5 min and the
[Ca2+]c peak during the release phase as an
inverse index for the efficacy of calcium extrusion. The value of this
ratio significantly increased from 17 to 33% when
[Na+]o was reduced from 140 to 65 mM
and even more at lower [Na+]o (Fig. 6). The
osmolarity of the medium was maintained at 325 mosM/liter
in these experiments by adding glucose. The reduced ability of the
cells to extrude Ca2+ in low [Na+]o
strongly supports a crucial role for the NCX in this process.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of the extracellular sodium
concentration on the cell ability to extrude calcium. Intact
fura-2-loaded glomerulosa cells were stimulated with 100 nM
AngII in calcium-free media containing various concentrations of
sodium. In each condition, the osmolality of the medium was maintained
at 325 mosM by adjunction of glucose. A plateau calcium
level ( plateau) was measured 3.5 min after the calcium release
peak, and its value was expressed as a percentage of the peak height
( peak). For each sodium concentration, 5-17 traces were analyzed,
and data were averaged. Control medium contained 140 mM
sodium. *** and ****, significantly different from control with
p < 0.005 and 0.001, respectively. Inset,
example of a calcium response recorded in a medium containing 15 mM sodium and illustrating the method for determining the
peak and plateau values.
|
|
Because the NCX exchanges three Na+ for one
Ca2+, it is electrogenic, and its activity therefore
decreases upon plasma membrane depolarization. Indeed, we observed that
upon the addition of 15 mM potassium, which depolarizes the
cells from their resting potential, 80 mV, to approximately 50 mV,
the rate of calcium extrusion was significantly reduced (Table
I) but remained sensitive to
caffeine.
View this table:
[in this window]
[in a new window]
|
Table I
Effect of potassium and modulators of protein kinase C on the rate of
calcium extrusion
Bovine glomerulosa cells were incubated a few minutes in a calcium-free
medium in the presence of various agents (18 mM KCl, 500 nM PMA, 2 µM CGP 41, 1-10 µM
chelerythrine chloride, or 0.2-1 µM calphostin C) and
with or without 10 mM caffeine before being stimulated with
100 nM AngII. Cytosolic calcium responses were recorded
with fura-2 or, in the case of chelerythrine, with fluo-3 or fluo-4.
The rate of calcium extrusion was then determined as described in the
legend to Fig. 4. Values obtained with untreated (control) cells are
indicated for comparison. Data are the mean ± S.E. from 5-37
determinations. NS, not significantly different; ND, not determined.
|
|
Mechanism of Angiotensin II Action on the
Sodium/Calcium Exchanger--
Because caffeine
accelerates Ca2+ extrusion more efficiently upon
stimulation with AngII, we hypothesized that the hormone inhibits the
exchanger and that the drug interferes with this regulatory pathway. We
therefore dissected the possible mechanisms of action employed by AngII
to modulate NCX activity.
PKC is known to be activated upon glomerulosa cell stimulation by AngII
but not by extracellular potassium (25). Therefore, this pathway
appeared first as a good candidate for playing a role in AngII action
on NCX. Indeed, we found that a pharmacological activation of PKC with
the phorbol ester PMA (500 nM) markedly slowed the
Ca2+ decrease phase after AngII (Table I), whereas, under
these conditions, the mechanism remained sensitive to caffeine, which
probably acts downstream of PKC. However, the results obtained with a
series of PKC inhibitors, used in order to mimic caffeine action, were not entirely consistent with a major role of PKC in the regulation of
the NCX activity. While the PKC inhibitor CGP41 (26), as expected,
significantly accelerated Ca2+ extrusion, other PKC
inhibitors such as chelerythrine chloride (27) and calphostin C (28)
had no significant effect (Table I).
These results suggest that PKC could participate in the negative
regulation of the exchanger, but it appears not to be absolutely required, and other mechanisms probably coexist. We therefore investigated alternative pathways activated by AngII and modulated by
PKC, such as the 12-lipoxygenase and the p42/44 and p38
mitogen-activated protein kinases.
A first clue in favor of the involvement of p38 MAPK was given by the
observation that Ca2+ extrusion is impaired when cells are
incubated in hypo-osmotic medium, a condition known to regulate,
positively or negatively, p38 MAPK activity in various cell types
(29-32). Indeed, reducing the osmolarity of the medium from a control
value of 325 down to 225 mosM/liter, significantly
increased the steady state Ca2+ plateau established after
Ca2+ release with AngII (Table
II). In these experiments,
[Na+]o was maintained constant at 65 mM, and the osmolarity was adjusted with various glucose
concentrations. In contrast, increasing the medium osmolarity to 425 mosM/liter had no notable effect on Ca2+
extrusion.
View this table:
[in this window]
[in a new window]
|
Table II
Effect of medium osmolarity on the rate of calcium extrusion
Bovine glomerulosa cells were stimulated with 100 nM AngII
in calcium-free media containing a fixed concentration of Na+
(65 mM) and with an osmolarity adjusted to various values
with different concentrations of glucose. Calcium responses were
determined with fura-2, and the ratio between the plateau (reached
after 3.5 min) and the peak was analyzed as described in the legend to
Fig. 6. NS, not significantly different.
|
|
We then directly tested the involvement of MAPKs by using specific
inhibitors. While the PD 98059 compound, selective for the p42/44 MAPK
(33), had no significant effect on the rate of Ca2+
extrusion (Table III) and did not prevent
the caffeine-induced acceleration of Ca2+ removal,
inhibition of the p38 MAPK with SB 203580 (34) resulted in a decrease
of the t1/2 value from 0.72 ± 0.04 to
0.51 ± 0.02 min (p < 0.001, n = 17). Most interestingly, in the presence of this inhibitor, caffeine
action was not any more significant, suggesting that caffeine and SB
203580 act on a common target.
View this table:
[in this window]
[in a new window]
|
Table III
Effect of lipoxygenase and MAPK inhibition on calcium extrusion
Bovine glomerulosa cells were incubated for 5-30 min in the presence
of various agents (50 µM PD 98059, an inhibitor of p42/44
MAPK, 10 µM SB 203580, an inhibitor of p38 MAPK, or 10 µM baicalein, an inhibitor of lipoxygenases) and with or
without 10 mM caffeine before being stimulated, in the
absence of extracellular calcium, with 100 nM AngII.
Cytosolic calcium responses were recorded with fluo-3 (PD and SB
compounds) or fura-2 (baicalein). The rate of calcium extrusion was
then determined as described in the legend to Fig. 4. Values obtained
with untreated (control) cells in the same experiments are also
indicated for comparison. Data are the mean ± S.E. from 5-17
determinations. NS, not significantly different.
|
|
Similarly, in Ca2+-containing medium, SB 203580 (20 µM) induced a rapid decrease of the AngII-induced
Ca2+ plateau levels, as previously observed in response to
caffeine (data not shown). Moreover, when SB was added 15-30 min
before AngII, the sustained Ca2+ phase (measured 3 min
after the hormone addition) was reduced from 24 ± 7 (in control
cells) down to 6 ± 2 nM (mean ± S.E., n = 3). In the presence of SB, the caffeine (3 mM) addition had no more effect on
[Ca2+]c levels, once again strongly suggesting
the existence of a common mechanism for caffeine and SB 203580 action.
In contrast, when both capacitative influx and Ca2+ entry
through voltage-operated Ca2+ channels were triggered in
the absence of AngII (by the simultaneous addition of 200 nM thapsigargin and 9 mM KCl), no effect of SB was observed on [Ca2+]c levels, therefore
excluding a direct effect of this drug on Ca2+ channel activity.
The lipoxygenases have been shown to be activated by AngII in adrenal
glomerulosa cells (18), and more specifically the product 12-HETE
appeared to be required for an optimal Ca2+ response (13).
In addition, p38 MAPK has been proposed to be regulated by the
lipoxygenase product 12-HETE (14). We therefore tested a possible role
of this pathway on the rate of Ca2+ extrusion. As shown in
Table III, the inhibitor of the 12-lipoxygenase, baicalein, also
accelerated Ca2+ decrease. However, baicalein did not
reduce caffeine action, which presumably acts downstream of lipoxygenase.
Finally, the time course of p38 MAPK activation by AngII and its
inhibition by caffeine and SB 203580 have been determined by measuring
the phosphorylated form of the enzyme with a specific antibody (Fig.
7). The hormone increased the active form
of the kinase by 22-fold within 2 min, without modifying the amount of total p38 MAPK (Fig. 7A). The time course analysis of this
activation was transient, with a maximal response between 2 and 5 min
and a decrease to basal values after 15 min (Fig. 7B).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 7.
Inhibition by caffeine of the
AngII-stimulated p38 MAPK. The activation of p38 MAPK upon
stimulation of glomerulosa cells with AngII (100 nM) was
determined in the presence of various agents, as described under
"Experimental Procedures." A, phosphorylated (activated)
and total p38 MAPK Western blot analysis in cells stimulated with AngII
for various periods. B, kinetics of p38 activation by AngII. The amount
of phosphorylated p38 MAPK present at different times was determined by
densitometry of the membrane shown in A and expressed as
-fold increase of the control value (n = 2).
C, kinetics of caffeine- and SB 203580-induced p38 MAPK
inhibition. Activity of p38 MAPK was determined after 4-min stimulation
with 100 nM AngII and in the presence of 10 mM
caffeine or 10 µM SB 203580 for the indicated periods of
time. Relative activity was expressed as a percentage of the activity
determined in control cells, stimulated in the absence of inhibitors.
The average basal (unstimulated) p38 activity in these experiments is
indicated by the dotted line. Data are the
mean ± S.E. from 3-5 independent experiments. D,
activation of p38 MAPK upon hypo-osmotic shock. Relative p38 MAPK
activity was determined in the absence (basal) or presence of AngII
(100 nM) in the same media as those described in the legend
of Table II. Results are the mean from two independent
experiments.
|
|
The ability of caffeine to prevent p38 MAPK activation was compared
with that of SB 203580 by adding the drugs in the medium at different
times before or during a 4-min stimulation with AngII (Fig.
7C). The addition of 10 µM SB into the medium
resulted in a rapid reduction of p38 MAPK phosphorylation levels by
~50% within 30 s. The inhibitory effect of SB tended to
diminish upon prolonged (> 20 min) treatment, but inhibition was
further reinforced (by 15%) when increasing the concentration of the
drug up to 100 µM (not shown).
Although slightly slower for inducing its effect, caffeine (10 mM), at 5 min, was as efficient as the SB compound (10 µM) at reducing AngII-induced p38 activation, and no
additional effect was observed when combining optimal concentrations of
caffeine and SB 203580 (not shown).
Moreover, in two independent experiments, baicalein (10 µM) also slightly reduced p38 activation (by 20%),
reinforcing the hypothesis that the 12-HETE products could act as
physiological activators of the kinase.
We have also determined the effect of medium osmolarity on p38 MAPK
activity. As illustrated in Fig. 7D, increasing medium osmolarity from 225 up to 425 mosM/liter led to a more than
50% reduction of basal p38 activity. Although the activation by AngII was particularly weak under these conditions (at low extracellular sodium concentration), the general tendency to obtain a higher p38
activity in hypo-osmotic medium was maintained in the presence of the hormone.
 |
DISCUSSION |
In the present study, we have unraveled a new cellular pathway
involved in the regulation of calcium homeostasis upon stimulation of
adrenal glomerulosa cells by AngII. While the presence of this pathway
was initially suggested by its sensitivity to caffeine, a largely
nonspecific drug, further investigation showed the involvement of well
characterized effectors, such as PKC, lipoxygenase, p38 MAPK, and the
NCX.
Caffeine action on the calcium signal elicited by AngII was robust and
reproducible enough to use this effect as a sort of marker for
analyzing the mechanisms involved in the hormone action. Moreover,
caffeine acted much more efficiently on the Ca2+ response
to AngII than on the response to extracellular potassium (Fig.
1C) or the Ca2+ ionophore, ionomycin (data not
shown), suggesting that the drug interfered with a pathway specifically
induced by AngII and not simply activated by an elevation of the
cytosolic calcium concentration. Finally, caffeine-induced inhibition
of the Ca2+ response to the hormone was translated in a
concomitant reduction of aldosterone production, highlighting the
physiological relevance of this observation.
Caffeine is known for its multiple actions on various targets involved
in cell signaling. In this context, we first showed that caffeine does
not influence Ca2+ through modulation of cAMP levels or
Ins(1,4,5)P3-induced Ca2+ release. Indeed, a
cross-talk between cAMP and the Ca2+ messenger system has
been described in many cell types with either potentiating or
antagonist properties. For example, by inhibiting the cAMP-specific
phosphodiesterases (35) caffeine could induce an elevation of basal
cytosolic cAMP concentration and subsequently activate
phospholamban-regulated Ca2+/Mg2+-ATPases (36).
This mechanism could have been responsible for the decrease of
[Ca2+]c observed upon the addition of caffeine.
To exclude this possibility, we have verified that neither forskolin, a
potent activator of adenylyl cyclases; 3-isobutyl-1-methylxanthine, an inhibitor of the phosphodiesterases; nor a cell-permeant analog of
cAMP, Bu2cAMP, could mimic or prevent caffeine action.
Similarly, caffeine has been proposed to directly affect
Ca2+ homeostasis, positively or negatively, through many
different mechanisms. The activation of Ca2+ release from
intracellular stores through stimulation of ryanodine-sensitive intracellular Ca2+ channels has been described in muscle
and nonmuscle cells for a very long time (37). However, opposite
effects of the drug have been also reported. In Xenopus
oocytes, caffeine has been shown to inhibit Ca2+
mobilization by preventing Ins(1,4,5)P3 action (38).
Similar results have been obtained with microsomes from rat or dog
cerebellum (39, 40). Caffeine has also been reported to decrease
phospholipase C activation by muscarinic receptor in guinea pig smooth
muscle (41) and to reduce the activity of voltage-gated
Ca2+ channels in rabbit artery (42) and GH3 cells (43).
In our study, all of these possible modes of caffeine action were
excluded by demonstrating that 1) there is no caffeine (or ryanodine)-sensitive stores in permeabilized bovine glomerulosa cells,
2) the presence of caffeine does not affect the response to
Ins(1,4,5)P3, and finally 3) the amplitude of the transient [Ca2+]c response was not affected by caffeine.
Whereas, at this stage of our investigations, the molecular mechanisms
involved in caffeine action remained unclear, the ultimate target of
the drug (i.e. the Ca2+ transporter affected by
the treatment) was also unknown. Because a change in
[Ca2+]c can result from a modification in the
rate of either Ca2+ influx into or of Ca2+
extrusion from the cytosol, we decided to simplify the system by
reducing the number of Ca2+ compartments. Indeed, by
measuring caffeine action in the absence of extracellular calcium, we
excluded a component of the response due to Ca2+ influx
from outside.
Under these new experimental conditions, caffeine appeared as an
activator of Ca2+ extrusion from the cytosol, and various
possible effectors involved in this transport were tested.
Thapsigargin, a specific inhibitor of the SERCA pumps (44), did not
significantly reduce the rate of Ca2+ extrusion after
release by AngII and did not prevent caffeine-induced acceleration of
this process. This finding strongly suggests that Ca2+
reuptake into the organelles is not the most efficient mechanism in
bovine glomerulosa cells to bring [Ca2+]c back to
basal levels, at least during a large elevation of
[Ca2+]c such as that elicited by an optimal
concentration of AngII, and that SERCAs are probably not the target of
caffeine action. This assumption is also supported by the observation
that 45Ca2+ uptake into the organelles of
permeabilized glomerulosa cells is not affected by caffeine.
Another relevant candidate for controlling Ca2+ removal
from the cytosol was the diltiazem-sensitive plasma membrane
sodium/calcium exchanger. Although diltiazem does not only affect NCX,
in the absence of extracellular Ca2+, the contribution of
diltiazem-sensitive Ca2+ channels is negligible. Actually,
the rate of Ca2+ extrusion was profoundly affected after
inhibition of the exchanger, not only pharmacologically with diltiazem
but also after reducing the driving force for this transport either by
decreasing the extracellular Na+ concentration or by
depolarizing the cells with potassium. Altogether, these observations
indicate that the NCX plays a crucial role in extruding cytosolic
Ca2+ and that its activity is rate-limiting. Moreover, this
mechanism is probably in great part responsible for the increase in
cytosolic Na+ concentration we previously observed in
bovine glomerulosa cells upon stimulation with AngII (5). More
importantly, after NCX inhibition, caffeine was unable to accelerate
Ca2+ extrusion. Thus, we propose that the NCX is this
ultimate effector affected by caffeine.
The activity of this exchanger is directly dependent on the levels of
[Ca2+]c, but caffeine affects more efficiently
the response to AngII than the response to extracellular potassium. We
therefore postulated that caffeine does not act directly on the
exchanger but on a regulatory step specifically elicited by AngII. In
fact, the acceleration of Ca2+ extrusion by caffeine is
believed to result from the relief of an inhibitory signal on the NCX
induced by the hormone itself. Indeed, calcium signaling upon
stimulation by AngII results from the opening of various
Ca2+ channels that will lead to an increase in
[Ca2+]c. If no other mechanism is involved by the
hormone, this Ca2+ elevation will trigger extrusion
mechanisms, like Ca2+ ATPases and the NCX, that will
immediately oppose this Ca2+ increase. The consequence will
be the creation of futile cycles of Ca2+ across the
membrane and therefore a waste of energy for the cell. In contrast, if
the hormone simultaneously stimulates Ca2+ entry and
reduces Ca2+ extrusion, the Ca2+ response is optimized.
Therefore, we investigated which pathway, sensitive to caffeine and
elicited by the hormone, could be responsible for the NCX inhibition.
In this regard, the involvement of PKC was strongly suggested by the
negative effect of PMA as well as the positive action of the PKC
inhibitor, CGP41, on the rate of Ca2+ extrusion. However,
two other pharmacological antagonists of the enzyme, chelerythrine
chloride and calphostin C, had no effect on this parameter. This
apparent contradiction could be explained by the fact that PKC could
act as a simple modulator of a signaling step that is directly
activated by AngII, independently of this enzyme. This step could be
mediated, for example, by a phospholipase A2 or a
diacylglycerol lipase, leading to the formation of arachidonic acid.
Alternatively, only specific isoforms of PKC, with various sensitivities to pharmacological inhibitors, could be involved in this
modulation. In this context, it is noteworthy that, in rat glomerulosa
cells, the lipoxygenase products 12- and 15-HETE have been shown to
specifically activate PKC- , whereas AngII stimulates both the and PKC isoforms (45).
The implication of the p38 MAPK in the modulation of the NCX activity
was first suggested by the observation that a low osmolarity in the
medium reduces, in an Na+-independent manner, the ability
of the cells to extrude calcium (Table II). Indeed, this kinase has
been shown to be involved in the response to various cellular stresses,
including osmotic shock (14). We therefore verified that AngII
effectively activates p38 MAPK, with kinetics in agreement with
an effect on the early Ca2+ response to the hormone. A more
than 10-fold increase in the activity of p38 within 1 min is perfectly
compatible with a role of this kinase in the regulation of
Ca2+ extrusion occurring immediately after the
Ca2+ release phase induced by AngII. Moreover, the presence
of a specific inhibitor of p38 MAPK, SB 203580, that reduces the
AngII-induced activation of the kinase by 50% within 30 s,
significantly accelerated Ca2+ extrusion (Table III),
mimicking and preventing caffeine action. These results suggest that
the SB compound and caffeine could act on the same target, a hypothesis
supported by the fact that caffeine prevents the activation of p38 by
AngII as efficiently as SB, although with slightly slower kinetics.
Although p38 MAPK is classically activated in most of the cell types by
an increase in medium osmolarity (hyperosmotic
shock), the opposite is apparently happening in bovine glomerulosa
cells, as already described in renal epithelial A6 cells by Niisato
et al. (29). The reason for this discrepancy between cell
types is still unclear, but our results are consistent with the
different rates of Ca2+ extrusion we have measured in the
present study in hypo- and hyperosmotic conditions and with the
observation by Makara et al. (46) that lowering osmolarity
leads to increased potassium-induced calcium response and aldosterone
production in rat adrenal glomerulosa cells.
From a teleological point of view, the inhibition of the NCX by a
kinase activated upon cell exposure to a low osmolar medium is
certainly an advantage for these cells. Indeed, the stoichiometry of
the exchanger allows the entry of 3 mol of Na+ when
extruding 1 mol of Ca2+, and this activity could be harmful
for the cell in a situation where it should rather expel osmolites to
the exterior.
In contrast to SB 203580, the inhibitor specifically blocking the
p42/44 MAPK, PD 98059, did not affect the kinetics of Ca2+
extrusion and did not prevent caffeine action, showing the specificity of the pathway involved in the control of the NCX.
In summary, our hypothesis that caffeine reduces AngII-evoked
Ca2+ signaling through an inhibition of p38 MAPK is
strongly supported by the fact that SB 203580 mimics caffeine action on
Ca2+ responses, that caffeine mimics the SB inhibitory
action on p38, and, most importantly, that none of these caffeine and
SB actions are additive when combining the two drugs.
The molecular link between p38 MAPK and NCX activity remains to be
demonstrated. The large increase in cytosolic sodium observed upon
bovine glomerulosa cell challenging with AngII (5), if not secondary to
NCX activation, could be responsible for reducing the activity of this
exchanger. In this regard, Kusuhara et al. (47) have
reported a modulation of the Na+/H+ exchanger
type 1 by MAPKs in vascular smooth muscle cells. However, whereas
Na+/H+ exchanger type 1 was activated by
p42/p44 MAPK, leading to an increase of intracellular Na+,
it was inhibited upon stimulation of p38 MAPK. It therefore appears that a major modulation of the NCX by AngII through
MAPK-dependent increase in sodium influx is unlikely in
bovine glomerulosa cells.
Finally, because the 12-HETE compound has been reported to activate p38
MAPK in H295R cells (21), we tested whether inhibition of lipoxygenases
with baicalein interferes with Ca2+ homeostasis. The
acceleration of Ca2+ extrusion by baicalein (Table III)
speaks in favor of the involvement of lipoxygenase products in the
modulation of the exchanger. Interestingly, caffeine remained efficient
after lipoxygenase inhibition, probably because caffeine acts
downstream of baicalein, a suggestion supported by the fact that the
latter slightly reduces the p38 MAPK activity.
In conclusion, our data strongly suggest that AngII, in parallel to the
activation of Ca2+ entry into adrenal glomerulosa cells,
also reduces Ca2+ extrusion from the cytosol through the
Na+/Ca2+ exchanger in order to prevent futile
cycling of Ca2+ across the plasma membrane. This modulation
of the exchanger activity involves lipoxygenases, the p38 MAPK, and
possibly some specific isoforms of PKC. The sensitivity of p38 MAPK
inhibition to caffeine explains the action of this drug on the
Ca2+ homeostasis previously observed upon stimulation with
AngII. Because of the ubiquity of this mechanism, possibly resulting from an ancestral mean of the cells to protect themselves against osmotic shocks, similar pathways are probably present in a variety of
cell types and could be elicited by various Ca2+-mobilizing hormones.
 |
ACKNOWLEDGEMENTS |
We are particularly grateful to Prof. A. M. Capponi for useful discussions and to C. Gerber-Wicht for
excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grant 32-58948.99 and by a grant from the Jubiläumsstiftung der
Schweizerischen Lebensversicherungs-und Rentenanstalt für Volksgesundheit und medizinische Forschung.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Division of
Endocrinology and Diabetology, University Hospital, 24 rue
Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. Tel.: 41-22-3729320;
Fax: 41-22-3729329; E-mail: rossier@cmu.unige.ch.
Published, JBC Papers in Press, April 30, 2002, DOI 10.1074/jbc.M110947200
 |
ABBREVIATIONS |
The abbreviations used are:
AngII, angiotensin
II;
Bu2cAMP, dibutiryl cyclic AMP;
TEMED, N,N,N',N'-tetraethylmethylene
diamine;
Ins(1, 4,5)P3, inositol 1,4,5-trisphosphate;
BAPTA, 1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid;
HETE, hydroxyeicosatetraenoic acid;
NCX, Na+/Ca2+ exchanger;
PKC, protein kinase C;
MAPK, mitogen-activated protein kinase;
MEK, mitogen-activated protein
kinase/extracellular signal-regulated kinase kinase;
ERK, extracellular
signal-regulated kinase;
PMA, phorbol 12-myristate 13-acetate.
 |
REFERENCES |
| 1.
|
Barrett, P. Q.,
Bollag, W. B.,
Isales, C. M.,
McCarthy, R. T.,
and Rasmussen, H.
(1989)
Endocr. Rev.
10,
496-518[Abstract/Free Full Text]
|
| 2.
|
Spät, A.,
Enyedi, P.,
Hajnoczky, G.,
and Hunyady, L.
(1991)
Exp. Physiol.
76,
859-885[Medline]
[Order article via Infotrieve]
|
| 3.
|
Capponi, A. M.,
Python, C. P.,
and Rossier, M. F.
(1994)
Endocrine
2,
579-586
|
| 4.
|
Barrett, P. Q.,
Isales, C. M.,
Bollag, W. B.,
and McCarthy, R. T.
(1991)
Am. J. Physiol.
261,
F706-F719[Medline]
[Order article via Infotrieve]
|
| 5.
|
Van der Bent, V.,
Demole, C.,
Johnson, E. I. M.,
Rossier, M. F.,
Python, C. P.,
Vallotton, M. B.,
and Capponi, A. M.
(1993)
Endocrinology
133,
1213-1220[Abstract/Free Full Text]
|
| 6.
|
Kojima, I.,
Kojima, K.,
Kreutter, D.,
and Rasmussen, H.
(1984)
J. Biol. Chem.
259,
14448-14457[Abstract/Free Full Text]
|
| 7.
|
Kojima, I.,
Shibata, H.,
and Ogata, E.
(1986)
Biochem. J.
237,
253-258[Medline]
[Order article via Infotrieve]
|
| 8.
|
Rossier, M. F.,
Aptel, H. B. C.,
Python, C. P.,
Burnay, M. M.,
Vallotton, M. B.,
and Capponi, A. M.
(1995)
J. Biol. Chem.
270,
15137-15142[Abstract/Free Full Text]
|
| 9.
|
Kojima, I.,
Kojima, K.,
and Rasmussen, H.
(1985)
Endocrinology
117,
1057-1066[Abstract/Free Full Text]
|
| 10.
|
Natarajan, R.,
Stern, N.,
and Nadler, J.
(1988)
Biochem. Biophys. Res. Commun.
156,
717-724[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Natarajan, R.,
Stern, N.,
Hsueh, W., Do, Y.,
and Nadler, J.
(1988)
J. Clin. Endocrinol. Metab.
67,
584-591[Abstract/Free Full Text]
|
| 12.
|
Natarajan, R.,
Dunn, W. D.,
Stern, N.,
and Nadler, J.
(1990)
Mol. Cell. Endocrinol.
72,
73-80[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Stern, N.,
Yanagawa, N.,
Saito, F.,
Hori, M.,
Natarajan, R.,
Nadler, J.,
and Tuck, M.
(1993)
Endocrinology
133,
843-847[Abstract/Free Full Text]
|
| 14.
|
Widmann, C.,
Gibson, S.,
Jarpe, M. B.,
and Johnson, G. L.
(1999)
Physiol. Rev.
79,
143-180[Abstract/Free Full Text]
|
| 15.
|
Chabre, O.,
Cornillon, F.,
Bottari, S. P.,
Chambaz, E. M.,
and Vilgrain, I.
(1995)
Endocrinology
136,
956-964[Abstract]
|
| 16.
|
Tian, Y.,
Smith, R. D.,
Balla, T.,
and Catt, K. J.
(1998)
Endocrinology
139,
1801-1809[Abstract/Free Full Text]
|
| 17.
|
McNeill, H.,
Puddefoot, J. R.,
and Vinson, G. P.
(1998)
Endocr. Res.
24,
373-380[Medline]
[Order article via Infotrieve]
|
| 18.
|
Natarajan, R.,
Gonzales, N.,
Hornsby, P. J.,
and Nadler, J.
(1992)
Endocrinology
131,
1174-1180[Abstract/Free Full Text]
|
| 19.
|
Smith, R. D.,
Baukal, A. J.,
Dent, P.,
and Catt, K. J.
(1999)
Endocrinology
140,
1385-1391[Abstract/Free Full Text]
|
| 20.
|
Natarajan, R.,
Scott, S.,
Bai, W.,
Yerneni, K. K.,
and Nadler, J.
(1999)
Hypertension
33,
378-384[Abstract/Free Full Text]
|
| 21.
|
Yang, D. C.,
Nadler, J.,
Lanting, L.,
and Natarajan, R.
(1999)
81st Annual Meeting of the Endocrine Society Abstracts
, p. 361, Endocrine Society Press, Bethesda, MD
|
| 22.
|
Rossier, M. F.,
Python, C. P.,
Capponi, A. M.,
Schlegel, W.,
Kwan, C. Y.,
and Vallotton, M. B
(1993)
Endocrinology
132,
1035-1043[Abstract/Free Full Text]
|
| 23.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 24.
|
Rossier, M. F.,
Krause, K.-H.,
Lew, P. D.,
Capponi, A. M.,
and Vallotton, M. B.
(1987)
J. Biol. Chem.
262,
4053-4058[Abstract/Free Full Text]
|
| 25.
|
Lang, U.,
and Vallotton, M. B.
(1987)
J. Biol. Chem.
262,
8047-8050[Abstract/Free Full Text]
|
| 26.
|
Meyer, T.,
Regenass, U.,
Fabbro, D.,
Alteri, E.,
Rosel, J.,
Muller, M.,
Caravatti, G.,
and Matter, A
(1989)
Int. J. Cancer
43,
851-856[Medline]
[Order article via Infotrieve]
|
| 27.
|
Herbert, J. M.,
Augereau, J. M.,
Gleye, J.,
and Maffrand, J. P.
(1990)
Biochem. Biophys. Res. Commun.
172,
993-999[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Bruns, R. F.,
Miller, F. D.,
Merriman, R. L.,
Howbert, J. J.,
Heath, W. F.,
Kobayashi, E.,
Takahashi, I.,
Tamaoki, T.,
and Nakano, H.
(1991)
Biochem. Biophys. Res. Commun.
176,
288-293[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Niisato, N.,
Post, M.,
Van Driessche, W.,
and Marunaka, Y.
(1999)
Biochem. Biophys. Res. Commun.
266,
547-550[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Roger, F.,
Martin, P. Y.,
Rousselot, M.,
Favre, H.,
and Feraille, E.
(1999)
J. Biol. Chem.
274,
34103-34110[Abstract/Free Full Text]
|
| 31.
|
Sugden, P. H.,
and Clerk, A.
(1998)
Circ. Res.
83,
345-352[Free Full Text]
|
| 32.
|
Zhang, Z.,
and Cohen, D. M.
(1996)
Am. J. Physiol.
271,
F1234-F1238[Medline]
[Order article via Infotrieve]
|
| 33.
|
Alessi, D. R.,
Cuenda, A.,
Cohen, P.,
Dudley, D. T.,
and Saltiel, A. R.
(1995)
J. Biol. Chem.
270,
27489-27494[Abstract/Free Full Text]
|
| 34.
|
Cuenda, A.,
Rouse, J.,
Doza, Y. N.,
Meier, R.,
Cohen, P.,
Gallagher, T. F.,
Young, P. R.,
and Lee, J. C.
(1995)
FEBS Lett.
364,
229-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Beavo, J. A.,
Rogers, N. L.,
Crofford, O. B.,
Hardman, J. G.,
Sutherland, E. W.,
and Newman, E. V.
(1970)
Mol. Pharmacol.
6,
597-603[Abstract/Free Full Text]
|
| 36.
|
James, P.,
Inui, M.,
Tada, M.,
Chiesi, M.,
and Carafoli, E.
(1989)
Nature
342,
90-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Bianchi, C. P.
(1961)
J. Gen. Physiol.
44,
845-858[Abstract/Free Full Text]
|
| 38.
|
Parker, I.,
and Ivorra, I.
(1991)
J. Physiol.
433,
229-240[Abstract/Free Full Text]
|
| 39.
|
Brown, G. R.,
Sayers, L. G.,
Kirk, C. J.,
Michell, R. H.,
and Michelangeli, F.
(1992)
Biochem. J.
282,
309-312[Medline]
[Order article via Infotrieve]
|
| 40.
|
Bezprozvanny, I.,
Bezprozvannaya, S.,
and Ehrlich, B. E.
(1994)
Mol. Biol. Cell
5,
97-103[Abstract]
|
| 41.
|
Prestwich, S. A.,
and Bolton, T. B.
(1995)
Br. J. Pharmacol.
114,
602-611[Medline]
[Order article via Infotrieve]
|
| 42.
|
Hughes, A. D.,
Hering, S.,
and Bolton, T. B.
(1990)
Pflugers Arch.
416,
462-466[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Kramer, R. H.,
Mokkapatti, R.,
and Levitan, E. S.
(1994)
Pflugers Arch.
426,
12-20[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Thastrup, O.,
Cullen, P. J.,
Drobak, B. K.,
Hanley, M. R.,
and Dawson, A. P.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2466-2470[Abstract/Free Full Text]
|
| 45.
|
Natarajan, R.,
Lanting, L., Xu, L.,
and Nadler, J.
(1994)
Mol. Cell. Endocrinol.
101,
59-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Makara, J. K.,
Petheo, G. L.,
Toth, A.,
and Spat, A.
(2000)
Endocrinology
141,
1705-1710[Abstract/Free Full Text]
|
| 47.
|
Kusuhara, M.,
Takahashi, E.,
Peterson, T. E.,
Abe, J.,
Ishida, M.,
Han, J.,
Ulevitch, R.,
and Berk, B. C.
(1998)
Circ. Res.
83,
824-831[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Casal, S. Ryser, A. M. Capponi, and C. F. Wang-Buholzer
Angiotensin II-Induced Mitogen-Activated Protein Kinase Phosphatase-1 Expression in Bovine Adrenal Glomerulosa Cells: Implications in Mineralocorticoid Biosynthesis
Endocrinology,
November 1, 2007;
148(11):
5573 - 5581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, J. A. Enyeart, and J. J. Enyeart
Angiotensin II inhibits native bTREK-1 K+ channels through a PLC-, kinase C-, and PIP2-independent pathway requiring ATP hydrolysis
Am J Physiol Cell Physiol,
August 1, 2007;
293(2):
C682 - C695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Payet, T. L. Goodfriend, L. Bilodeau, C. Mackendale, L. Chouinard, and N. Gallo-Payet
An oxidized metabolite of linoleic acid increases intracellular calcium in rat adrenal glomerulosa cells
Am J Physiol Endocrinol Metab,
December 1, 2006;
291(6):
E1160 - E1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otis and N. Gallo-Payet
Differential Involvement of Cytoskeleton and Rho-Guanosine 5'-Triphosphatases in Growth-Promoting Effects of Angiotensin II in Rat Adrenal Glomerulosa Cells
Endocrinology,
November 1, 2006;
147(11):
5460 - 5469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gambaryan, E. Butt, P. Tas, A. Smolenski, B. Allolio, and U. Walter
Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP
Am J Physiol Endocrinol Metab,
March 1, 2006;
290(3):
E423 - E433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cartier, S. Jegou, F. Parmentier, I. Lihrmann, E. Louiset, J.-M. Kuhn, C. Bastard, P.-F. Plouin, M. Godin, H. Vaudry, et al.
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas
Eur. J. Endocrinol.,
December 1, 2005;
153(6):
939 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet
Angiotensin II Stimulates Protein Synthesis and Inhibits Proliferation in Primary Cultures of Rat Adrenal Glomerulosa Cells
Endocrinology,
February 1, 2005;
146(2):
633 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev,
April 1, 2004;
84(2):
489 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino
Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells
Endocrinology,
February 1, 2004;
145(2):
639 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lalevee, V. Resin, S. Arnaudeau, N. Demaurex, and M. F. Rossier
Intracellular Transport of Calcium from Plasma Membrane to Mitochondria in Adrenal H295R Cells: Implication for Steroidogenesis
Endocrinology,
October 1, 2003;
144(10):
4575 - 4585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Campbell, M. Otis, M. Cote, N. Gallo-Payet, and M. D. Payet
Connection between Integrins and Cell Activation in Rat Adrenal Glomerulosa Cells: A Role for Arg-Gly-Asp Peptide in the Activation of the p42/p44mapk Pathway and Intracellular Calcium
Endocrinology,
April 1, 2003;
144(4):
1486 - 1495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gu, Y. Wen, A. Mison, and J. L. Nadler
12-Lipoxygenase Pathway Increases Aldosterone Production, 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein Phosphorylation, and p38 Mitogen-Activated Protein Kinase Activation in H295R Human Adrenocortical Cells
Endocrinology,
February 1, 2003;
144(2):
534 - 543.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|